Oncology
Joshua Brody, M.D.
Professor of Medicine, Hematology and Medical Oncology; Professor of Oncological Sciences; Professor of Immunology & Immunotherapy; Director of the Lymphoma Immunotherapy Program
Joshua Brody, MD, is a medical oncologist specializing in lymphoma immunotherapy at the Mount Sinai Tisch Cancer Center in New York, NY. As Director of the Lymphoma Immunotherapy Program, he focuses on treating adult patients with non-Hodgkin's lymphoma, Hodgkin's lymphoma, mantle cell lymphoma, primary central nervous system lymphoma, leukemia, and other lymphatic system disorders. He serves primarily adult populations, developing novel therapies through his translational Cancer Immunotherapy L
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABMS)
- Hematology & Oncology (ABMS)
- American Board of Internal Medicine
Education & Training
- Fellowship, Medical Oncology, Stanford University School of Medicine
- Residency, Internal Medicine, Yale New Haven Hospital
- MD, State University of New York Stony Brook School of Medicine
- BA, Harvard University
Recognition & Leadership
Awards & Honors
- 2011 Society for Immunotherapy of Cancer Presidential Award (SITC 26th Annual Meeting)
- 2011 SCL Award for top abstract submitted to 2011 International Conference on Malignant Lymphoma
- 2011 ASCO Merit Award for top 100 abstracts submitted to 2011 Annual Meeting
- 2009 Howard Temin Pathway to Independence Award in Cancer Research (K99/R00)
- 2009 Outstanding Recent Graduate, SUNY Stony Brook School of Medicine
Leadership Roles
- Director, Lymphoma Immunotherapy Program
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Mount Sinai Queens
- Ruttenberg Treatment Center
- Mount Sinai Hospital
Languages
English
Experience
25+ years in practice